Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03567187 · ClinicalTrials.gov registry record · NA
Cryoneurolysis for Improvements in Pain, ADL and QOL in Patients With Ankle Osteoarthritis
A NA study, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT03567187 is a NA study that has completed, run by University of Kansas Medical Center. The registered enrollment target is 40 participants.
The verdict
NCT03567187, a NA study, has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This will be an open-label trial to describe the effects of cryoneurolysis with iovera° on symptom relief in patients with painful Kellgren-Lawrence (KL) grade 2-4 ankle osteoarthritis (OA). The Foot and Ankle Outcome Score (FAOS) subscales will be used to assess outcomes at 6, 12 and 24 weeks after treatment.
Interventions
- DEVICE iovera
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2018-07-03 |
| Est. Completion | 2021-01-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03567187
The ClinicalTrials.gov registry entry for NCT03567187 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which iovera is the first listed.
NCT03567187 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03567187 about?
NCT03567187 is a clinical study titled "Cryoneurolysis for Improvements in Pain, ADL and QOL in Patients With Ankle Osteoarthritis". This will be an open-label trial to describe the effects of cryoneurolysis with iovera° on symptom relief in patients with painful Kellgren-Lawrence (KL) grade 2-4 ankle osteoarthritis (OA). The Foot and Ankle Outcome Score (FAOS) subscales will be used to assess outcomes at 6, 12 and 24 weeks after...
What is the current status of trial NCT03567187?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2018-07-03. Estimated completion is 2021-01-28.
What interventions are being tested in trial NCT03567187?
The interventions under investigation include: iovera (DEVICE).
Who is sponsoring clinical trial NCT03567187?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.